Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1 M ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Discover Microbix Biosystems' strong Q1 2025 earnings, 40% revenue growth, and operational gains. Learn about innovative launches & fiscal growth strategies.

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

Overall, strong Q1 revenues and improved margins led to net income of $856,962 without any Kinlytic-related revenues versus Q1 2024 net income of $2,455,379 inclusive of Kinlytic-related revenues.

Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

EV Resources has confirmed high-grade antimony samples from first assays at its newest potential near-term production asset Los Lirios in Oaxaca, Mexico.

The Korea Research Institute of Standards and Science (KRISS) has developed a safety evaluation technology for nanoparticles* ...

Silver Tiger Metals (SLVTF) has received the first assay results from the drilling campaign being conducted from underground drill pads ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...